PubMed HealthSearch

SEARCH · PubMed Health

Results for “Poales”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

17 recordsLinked to original sources

The genome sequence of Carex sylvatica Huds., 1762 (Poales: Cyperaceae).

We present a genome assembly of Carex sylvatica (Wood-sedge; Streptophyta; Magnoliopsida; Poales; Cyperaceae). The genome sequence has a total length of 363.24 megabases. Most of the assembly (99.79%) is scaffolded into 29 chromosomal pseudomolecules. The mitochondrial sequences have lengths of 1715.64, 74.78 and 77.37 kilobases and the plastid genome assembly has a length of 215.14 kilobases. This assembly was generated as part of the Darwin Tree of Life project, which produces reference genomes for eukaryotic species found in Britain and Ireland.

Carex sylvatica

The genome sequence of Schoenoplectus triqueter (L.) Palla, 1888 (Poales: Cyperaceae).

We present a genome assembly of Schoenoplectus triqueter (Triangular Club-rush; Streptophyta; Magnoliopsida; Poales; Cyperaceae). The genome sequence has a total length of 580.26 megabases. Most of the assembly (98.75%) is scaffolded into 21 chromosomal pseudomolecules. Five mitochondrial sequences and the plastid genome were also assembled. Gene annotation of this assembly on Ensembl identified 31 746 protein-coding genes. This assembly was generated as part of the Darwin Tree of Life project, which produces reference genomes for eukaryotic species found in Britain and Ireland.

Poales

The scalp topography of human somatosensory and auditory evoked potentials.

The waveform and topography of components of the scalp recorded somatosensory evoked poal (AEP) to click stimulation of the right ear, were determined for scalp electrode locations of the 10-20 system and for locations at the eye, mastoids, and posterior neck. Twenty-one SEP and twenty-two AEP components were analyzed. Differentiation of neurogenic and myogenic components was attempted on the basis of localization and variability. Some components of extracranial origin, apparently originating in frontal musculature, were small in most experienced subjects and large in most experimentally naive subjects. These and other presumptive myogenic potentials can distort adjacent neurogenic components. These data should aid in predicting SEP and AEP characteristics and in assessing myogenic distortion of neurogenic components.

Adolescent

Meclofenamate sodium in the treatment of ankylosing spondylitis. Report of a European double-blind controlled multicenter study.

98 patients with reversible, definite, active ankylosing spondylitis were selected for this study. 49 patients were treated with N-(2,6-dichloro-m-tolyl)anthranilic acid, sodium salt (meclofenamate sodium, Meclomen) and 49 patients with indometacin. Following a single-blind baseline period on placebo, patients received either 200 mg meclofenamate sodium per day or 100 mg indometacin per day for one week, in the second week the doses were increased to 250 mg meclofenamate sodium and 125 mg indometacin and from the third through the eight week 300 mg meclofenamate sodium and 150 mg indometacin were given. The results of this double-blind study showed that similar improvement in mobility of the vertebral column and spondylitic pain could be achieved with meclofenamate sodium and indometacin in patients with ankylosing spondylitis. Although both treatments were well tolerated fewer meclofenamate sodium patients reported adverse reactions than did those who had received indometacin. It is concluded that meclofenamate sodium offers an effective and safe alternative to indometacin in the treatment of patients with ankylosing spondylitis.

Adolescent